Combined with surgical margin status, clinically applied prognostic factors such as prostate specific antigen (PSA) value, tumor-node-metastasis (TNM) status and Gleason score can help assess the risk of relapse after RP (7). This evidence concerns the gene KLK3 and neoplasm.